http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35532809

Outgoing Links

Predicate Object
contentType Journal Article
issn 1750-3639
1015-6305
pageRange e13198-
publicationName Brain pathology (Zurich, Switzerland)
startingPage e13198
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_65b218eb97d951ab650808a1df3c586f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3e0cc103e50dc545d24adc1d7e46eba5
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dbae2a3af0b52022c87ff6fdcc279147
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb074666a91166065aacae403afee8d9
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
bibliographicCitation Liu L, Zhang KN, Zhao Z, Li G, Chai RC, Li Z, Liu X, Chen J, Jiang T. MET fusions and splicing variants is a strong adverse prognostic factor in astrocytoma, isocitrate dehydrogenase mutant. Brain Pathol. 2023 Aug 02;():e13198. doi: 10.1111/bpa.13198. PMID: 37530224.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06ef11c9c0dcbb9e418fecd02c7ab442
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e8cc39f883db40db067f481be6956e7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daeba40cd0e3266beb94375f431052a4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7fae0cb8acc63cb78750fd303fb330b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3502f06d209641d2865b058ec3ce783d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b40277391c39f6ec046a8c1cfa9ac098
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7008-6351
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62bac00745126426438999eeda2e20f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3451-8871
date 2023-08-02^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1111/bpa.13198
https://pubmed.ncbi.nlm.nih.gov/37530224
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2602
https://portal.issn.org/resource/ISSN/1750-3639
https://portal.issn.org/resource/ISSN/1015-6305
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title MET fusions and splicing variants is a strong adverse prognostic factor in astrocytoma, isocitrate dehydrogenase mutant
discusses http://id.nlm.nih.gov/mesh/M0011751

Showing number of triples: 1 to 33 of 33.